123536-14-1, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 123536-14-1, molecular formula is C7H16Cl2N2, introducing its new discovery.
PHARMACEUTICAL COMPOUNDS
The invention relates to compounds and compositions for inhibiting the enzyme fatty acid amide hydrolase (FAAH), the use of the compounds in therapy and, in particular, for treating or preventing conditions whose development or symptoms are linked to substrates of the FAAH enzyme, and methods of treatment or prevention using the compounds and compositions.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.123536-14-1, you can also check out more blogs about123536-14-1
Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H114N | ChemSpider